Stock Ratings / Health Care / QTEX / financials

LNSR (24) MBOT (41) DAVI (47) SKIN (36) ⌘ Pro Terminal →

QTREX Quantum Ltd. (QTEX) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$1.22 -7.58% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.20

QTREX Quantum Ltd. (QTEX) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $73.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on QTEX Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is QTEX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, QTREX Quantum Ltd. (NASDAQ: QTEX) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $1.22 (-7.58% 1D, market cap $73.9M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, QTEX ranks #816 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does QTEX compare to LNSR and MBOT in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), QTEX carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 0.7%, and ROIC of -35.0%. By comparison, LNSR (LENSAR Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $73.3M) and MBOT (Microbot Medical Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -15.8%, cap $75.2M). Among the 5-stock peer group, QTEX leads on earnings multiple (N/A) while MBOT leads on capital efficiency (-15.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for QTEX?

▼

Per QTEX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001837493), QTREX Quantum Ltd. generated $289.0K in revenue, -$13.2M in net income, and -$10.0M in free cash flow against $5.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.20 (-1.55%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-12.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for QTEX)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (31/100 Composite)

🔍 WHY QTEX SCORES 31/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (26% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9

▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 0.2% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.87-19.8% Next Q

Q2 (-2Q)

Grade E$1.50-7.3% Next Q

Q3 (-1Q)

Grade E$1.39-12.2% Next Q

Current

Grade E$1.22-9.4% Hist 90D α

Trajectory: E (39) → E (31)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a QTEX Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While QTEX currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.09) and Max Pain ($1.28) forces dealer call-delta covering toward $4.04.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $QTEX• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “QTEX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 31%NO 69%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How QTEX Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $1.0M

FY24

Rev $1.0M

FY25

Rev $289.0K

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$289.0K	0.7%	-80%	-$13.2M	-$10.0M	-45%
FY 2024	$1.0M	8%	-1126.7%	-$11.1M	-$9.5M	-45%
FY 2023	$1.0M	8%	-1213.3%	-$11.3M	-$9.7M	-35%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring QTEX)

✓Walkthrough of QTEX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

QTEX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +177.27%📐 HORIZONTAL RANGE

2026-10-30O $1.25H $1.25L $1.18C $1.22VOL 2.70M

RES: $2.17SUP: $0.44SMA50: $1.09SMA200: $0.97

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

QTEX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 QTEX Butterfly Map → + Track QTEX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on QTEX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for QTEX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for QTEX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (QTEX)

Health Care Rank #816 of 1016 ⚔️ LNSR vs QTEX Full Matrix →

1. Head-to-Head Health Care Peer Comparison (QTEX vs. LNSR, MBOT, DAVI, SKIN)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, QTREX Quantum Ltd. (QTEX) ranks #816 by composite RQD confidence (31/100, grade E) and #699 by equity capitalization ($73.9M). Within this direct 5-issuer industry benchmark cohort, QTEX leads on earnings valuation at N/A trailing P/E, while MBOT leads on capital efficiency and profitability with -15.8% ROIC and — gross margin. DAVI currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with QTEX at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
QTEX ACTIVE QTREX Quantum Ltd.	E	31/100	—	0.7%	-35.0%	-7.58%	$73.9M	Benchmark Subject
LNSR LENSAR Inc.	E	24/100	—	39.4%	-35.0%	-2.18%	$73.3M	/lnsr-vs-qtex →
MBOT Microbot Medical Inc.	D-	41/100	—	—	-15.8%	-2.68%	$75.2M	/mbot-vs-qtex →
DAVI Davion Healthcare Plc	D	47/100	—	—	—	-37.55%	$67.3M	/davi-vs-qtex →
SKIN SkinHealth Systems Inc. (Class A)	D-	36/100	—	65.3%	-26.9%	-2.07%	$66.0M	/skin-vs-qtex →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001837493

In its most recent audited fiscal period (FY2025, filed 2025-12-31), QTREX Quantum Ltd. (QTEX) reported GAAP revenue of $289.0K (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$13.2M, operating cash flow of -$9.9M, and free cash flow of -$10.0M (-4.5% YoY). On the balance sheet, QTEX closed FY2025 with $5.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$289.0K	-$13.2M	-$9.9M	-$10.0M	$5.3M	—
FY2024 (FY)	2024-12-31	$0	-$11.1M	-$9.4M	-$9.5M	$8.1M	—
FY2023 (FY)	2023-12-31	$0	-$11.3M	-$9.7M	-$9.7M	—	—

3. QTEX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is QTEX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does QTEX compare to LNSR and MBOT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for QTEX?

Where is QTEX trading relative to its 50-day, 200-day, and 52-week technical levels?

QTEX last traded at $1.22 (-7.58% on volume of 2,795,072 shares), positioning the stock +11.93% above its 50-day simple moving average ($1.09) and +25.77% above its 200-day simple moving average ($0.97). Across its 52-week range of $0.28 to $3.85, QTEX sits at the 26.3% percentile with a 14-day RSI of 46.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.07 to $1.37).

QTEX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is QTREX Quantum Ltd. (QTEX)?

In FY 2025 (10-K), QTEX converted $1.0M of revenue into a 0.2% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

Direct Sub-Reports: QTEX RQD Cockpit QTEX 12M Forecast QTEX Earnings & Move QTEX Dividends & DRIP QTEX Insiders & 13F QTEX Whale Options QTEX Profit Sankey QTEX News & Why

Sector Peer Dials

Microbot Medical Inc.

41 /100

DAVI D

Davion Healthcare Plc

47 /100

SKIN D-

SkinHealth Systems Inc. (Class A)

36 /100

LUCD D

Lucid Diagnostics Inc.

QTEX Core Snapshot

Market Cap $73.9M

Trailing / Fwd P/E — / —

Gross Profit Margin 0.7%

Return on Capital (ROIC) -35.0%

Free Cash Flow Yield -13.49%

12M Base Price Target $1.07

FREE TRADER TOOLS

Own QTEX Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With QTEX → 🏆 Trade QTEX in $100K Prop Arena →

QTEX Wire

Why It Moved →

Peer / Ecosystem Wire Yahoo • 14d ago

QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement

Peer / Ecosystem Wire Benzinga • 14d ago

QTREX Quantum Regains Nasdaq Compliance

Peer / Ecosystem Wire Yahoo • 18d ago

Correction: QTREX Quantum Announces Clean Capital Structure

Peer / Ecosystem Wire Yahoo • 18d ago

QTREX Quantum Announces Clean Capital Structure

Peer / Ecosystem Wire Yahoo Finance • 23d ago

QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

ROARABLE RATING BRIEF • RQD 31/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

QTEX — QTREX Quantum Ltd.: What the Facts Mean to a Prospective Investor

Engine: roarable-bundle-v1

As of: 2026-11-02T15:08:05Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD 5-pillar rating engine, QTREX Quantum Ltd. (QTEX) carries a composite score of 31 / 100 (E — Roarable Strong Sell — Forensic Risk / Avoid).\n- Fundamental Cash Engine (7 / 20): Return on invested capital (ROIC) registers at -35.0% with a free cash flow yield of -13.49% and gross margin of 0.7%.\n- Institutional 13F Whale Flow (7 / 20): Tracks institutional accumulation and dark-pool/options positioning relative to the Medical/Dental Instruments cohort.\n- Insider & Congressional Conviction (3 / 20): Evaluates open-market Form 4 executive purchases and Congressional PTR disclosures.\n- Macro Regime Fit (6 / 20): Equity beta of 1.00 across the Health Care sector.\n- Forensic Balance-Sheet Shield (8 / 20): Altman Z-Score of 2.50, Piotroski F-Score of 2/9, and Debt-to-Equity of 0.50.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %	\n	---	---	---	---	---	---	---	---	---	---	\n	$1.22	$73.9M	N/A	N/A	N/A	N/A	0.00%	1.00	$0.28 - $3.85	-35.0%

Business & Sector Positioning

QTREX Quantum Ltd. (QTEX) is a NASDAQ-listed Health Care issuer operating in Medical/Dental Instruments with a market capitalization of $0.1B.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Operating within Medical/Dental Instruments (Health Care), QTEX exhibits an operating margin of -60.0% and net margin of -60.0%. Prospective investors should monitor 2nd-order capex cycles, input cost pass-through in gross margin (0.7%), and valuation discipline (current multiple) relative to free cash flow conversion.

Open Questions for Prospective Investors

How sustainable is QTEX's current operating margin (-60.0%) and ROIC (-35.0%) over the next four quarters?\n2. Does the current valuation multiple (current EV/EBITDA) adequately discount macro sensitivity (Beta 1.00) in Medical/Dental Instruments?\n3. Will upcoming quarterly cash flow conversion support continued balance-sheet strength (Altman Z 2.50)?

QTEX Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for QTREX Quantum Ltd. (QTEX) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to QTEX Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo • 14d ago

QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement

Ness Ziona, Israel, Oct. 19, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrast

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 14d ago

QTREX Quantum Regains Nasdaq Compliance

QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, announced today that

Read Full Source ↗

🟡 MARKET WIRE Yahoo • 18d ago

Correction: QTREX Quantum Announces Clean Capital Structure

6,785,715 warrant shares registered in July 2026 exercised in full. QTREX currently has no investor warrants, ATM, and no convertible securities outstandingNess Ziona, Oct. 14, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd.

Read Full Source ↗

🟡 MARKET WIRE Yahoo • 18d ago

QTREX Quantum Announces Clean Capital Structure

6,785,715 warrant shares registered in July 2026 exercised in full. Qtrex currently has no investor warrants at the market programs, and no convertible securities outstandingNess Ziona, Oct. 14, 2026 (GLOBE NEWSWIRE) --

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 23d ago

QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Shares back above $1.00 for 6 consecutive trading days Ness Ziona, Israel, Oct. 09, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) (“QTREX” or the “Company”), a company focused on advancing Additively Manufac

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 32d ago

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader

On the strength of these results, definitive agreement with the testing company being finalized; its name, business and the full agreement to be disclosed within weeks.Ness Ziona, Oct. 01, 2026 (GLOBE NEWSWIRE) -- QTREX

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 39d ago

QTREX Quantum Reports First Half 2026 Financial Results

Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Record first half revenue of $1.55 million, up 438%, at a 61% gross margin, all generated by the AME and Quantum segment in its first 86 days after being acquired by

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 61d ago

One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology

Ness Ziona, Sept. 02, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

QTEX Bull vs. Bear Conversation Board — What's Your Call at $1.22?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON QTEX 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.07 (-12.3%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is QTEX (E • RQD 31/100) a Buy at $1.22?

Welcome to the QTEX (QTREX Quantum Ltd.) Roar Pit. Current RQD Composite is 31/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $0.96 (-21.3%)

Spot @ $1.22

Pump the brakes on QTEX — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on QTEX, but look at what you are paying: current EV/EBITDA multiples with 0.7% gross margins. Unless QTREX Quantum Ltd. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.39 (+13.9%)

Spot @ $1.22

QTEX cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on QTEX, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $1.22 (52-wk range $0.28 - $3.85), any beat on forward guidance forces shorts and underweight funds to chase.